Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Autoimmune Neurological Disorders and Treatments, Peripheral Neuropathies and Disorders, Neuroscience and Neuropharmacology Research, and Multiple Sclerosis Research Studies.
The Clinical Trial Landscape in Autoimmune Encephalitis
Chimeric antigen receptor T cells in treatment-refractory DAGLA antibody-associated encephalitis
Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2
Brain atrophy patterns in anti-IgLON5 disease
Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study)
Risk of Epilepsy and Factors Associated With Time to Seizure Remission in Anti-LGI1 Encephalitis
Targeted rescue of synaptic plasticity improves cognitive decline in sepsis-associated encephalopathy
Activity-driven synaptic translocation of LGI1 controls excitatory neurotransmission
Converging synaptic and network dysfunctions in distinct autoimmune encephalitis
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Microglia mediate neurocognitive deficits by eliminating C1q-tagged synapses in sepsis-associated encephalopathy
Human NMDAR autoantibodies disrupt excitatory-inhibitory balance, leading to hippocampal network hypersynchrony
Impaired functional connectivity of the hippocampus in translational murine models of NMDA-receptor antibody associated neuropsychiatric pathology
Real-world data on eculizumab treatment in NMOSD: high efficacy and potential challenges (P13-5.017)
Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease
Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitis
eSurgery—digital transformation in surgery, surgical education and training: survey analysis of the status quo in Germany
Activity-driven synaptic translocation of LGI1 controls excitatory neurotransmission
Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis
CSF Findings in Acute NMDAR and LGI1 Antibody–Associated Autoimmune Encephalitis
Encephalitis patient-derived monoclonal GABAA receptor antibodies cause epileptic seizures.
N‐methyl‐D‐aspartate receptor dysfunction by unmutated human antibodies against the NR1 subunit
Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders
Apheresis therapies for NMOSD attacks
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
Influence of female sex and fertile age on neuromyelitis optica spectrum disorders
Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy